Molecular Devices - Neurotransmitter Transporter Assay

Manufactured by  Molecular Devices
Follow this Equipment

The homogeneous Neurotransmitter Transporter Uptake Assay Kit provides a fast, simple, and reliable fluorescence-based...

The homogeneous Neurotransmitter Transporter Uptake Assay Kit provides a fast, simple, and reliable fluorescence-based assay for the detection of dopamine, norepinephrine, and serotonin transporter (DAT, NET and SERT, respectively) activity in expressing cells, transfected or primary. 
Neurotransmitter transporters have become important pharmaceutical targets, as they play a key role in depression and neurodegenerative diseases (NDD) such as Alzheimer's and Parkinson's diseases. The ability to monitor serotonin, norepinephrine and dopamine neurotransmitter uptake is key to a better understanding of these diseases. 
Until recently, radioactively labeled compounds were used to measure serotonin, norepinephrine, and dopamine transporter uptake. With the introduction of this novel assay kit, researchers now have a tool to screen for live-cell kinetic uptake for these three key neurotransmitters in a homogeneous, fluorescence-based, high-throughput format. The assay can be performed either as a real-time kinetic assay suitable for mechanistic studies or as an HTS-amenable endpoint read.
Active Questions & AnswersAsk a Question

There are no current Discussions

Need Equipment Support?

Request Support
Documents & Manuals

There are no Documents or Manuals available.

Features of Neurotransmitter Transporter Assay

Benefits of the Neurotransmitter Transporter Uptake Assay Kit 

  • Homogeneous, live-cell fluorescent assay replaces radioactive assays, reducing disposal costs and eliminating safety risks associated with radiolabeled assays. 
  • One-step, homogeneous assay format is amenable to automation and high-throughput screening. 
  • Two assay setup options offer greater flexibility: endpoint mode for high-throughput applications, or real-time kinetic mode for mechanistic studies. 

Patented technology  This assay utilizes a Molecular Devices masking dye to extinguish extracellular fluorescence. This masking dye technology has been exclusively licensed from Bayer AG (U.S. Patent Nos. 6,420,183, 7,063,952, 7,138,280 and European Patent No. 0,906,572). The assay also includes a novel proprietary fluorescent indicator dye that mimics the neurotransmitters serotonin, norepinephrine, and dopamine, and is actively transported into the cells via the neurotransmitter transporters.

General Specifications

There are no General Specifications available.

Looking for New or Used Equipment?

Shop on LabX

Shop on